74 related articles for article (PubMed ID: 21358350)
1. The relation between body mass index and speaking fundamental frequency in premenopausal and postmenopausal women.
D'haeseleer E; Depypere H; Claeys S; Van Lierde KM
Menopause; 2011 Jul; 18(7):754-8. PubMed ID: 21358350
[TBL] [Abstract][Full Text] [Related]
2. Comparison of speaking fundamental frequency between premenopausal women and postmenopausal women with and without hormone therapy.
D'haeseleer E; Depypere H; Van Lierde K
Folia Phoniatr Logop; 2013; 65(2):78-83. PubMed ID: 23948697
[TBL] [Abstract][Full Text] [Related]
3. Effect of climacteric transition and hormone replacement therapy on body weight and body fat distribution.
Genazzani AR; Gambacciani M
Gynecol Endocrinol; 2006 Mar; 22(3):145-50. PubMed ID: 16835076
[TBL] [Abstract][Full Text] [Related]
4. Serum leptin concentrations in pre- and postmenopausal women on sex hormone therapy.
Bednarek-Tupikowska G; Filus A; Kuliczkowska-Płaksej J; Tupikowski K; Bohdanowicz-Pawlak A; Milewicz A
Gynecol Endocrinol; 2006 Apr; 22(4):207-12. PubMed ID: 16723307
[TBL] [Abstract][Full Text] [Related]
5. Effects of pre- and postmenopausal use of exogenous hormones on receptor content in normal human breast tissue: a randomized study.
Hallberg G; Persson I; Naessén T; Magnusson C
Gynecol Endocrinol; 2008 Aug; 24(8):475-80. PubMed ID: 18850387
[TBL] [Abstract][Full Text] [Related]
6. Correlation between estrogens and serum adipocytokines in premenopausal and postmenopausal women.
Hong SC; Yoo SW; Cho GJ; Kim T; Hur JY; Park YK; Lee KW; Kim SH
Menopause; 2007; 14(5):835-40. PubMed ID: 17667144
[TBL] [Abstract][Full Text] [Related]
7. Role of ovarian hormones in the regulation of protein metabolism in women: effects of menopausal status and hormone replacement therapy.
Toth MJ; Sites CK; Matthews DE
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E639-46. PubMed ID: 16684855
[TBL] [Abstract][Full Text] [Related]
8. Body mass, depressive symptoms and menopausal status: an examination of the "Jolly Fat" hypothesis.
Jasienska G; Ziomkiewicz A; Górkiewicz M; Pajak A
Womens Health Issues; 2005; 15(3):145-51. PubMed ID: 15894200
[TBL] [Abstract][Full Text] [Related]
9. The impact of hormone therapy on vocal quality in postmenopausal women.
D'haeseleer E; Depypere H; Claeys S; Baudonck N; Van Lierde K
J Voice; 2012 Sep; 26(5):671.e1-7. PubMed ID: 22578434
[TBL] [Abstract][Full Text] [Related]
10. Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene.
Tommaselli GA; Di Carlo C; Di Spiezio Sardo A; Bifulco G; Cirillo D; Guida M; Capasso R; Nappi C
Menopause; 2006; 13(4):660-8. PubMed ID: 16837888
[TBL] [Abstract][Full Text] [Related]
11. Differences in the estrogen content of breast adipose tissue in women by menopausal status and hormone use.
O'Brien SN; Anandjiwala J; Price TM
Obstet Gynecol; 1997 Aug; 90(2):244-8. PubMed ID: 9241302
[TBL] [Abstract][Full Text] [Related]
12. The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women.
Osmanagaoglu MA; Okumuş B; Osmanagaoglu T; Bozkaya H
J Womens Health (Larchmt); 2004 Nov; 13(9):993-9. PubMed ID: 15665656
[TBL] [Abstract][Full Text] [Related]
13. Plasma adiponectin concentration in healthy pre- and postmenopausal women: relationship with body composition, bone mineral, and metabolic variables.
Jürimäe J; Jürimäe T
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E42-7. PubMed ID: 17341545
[TBL] [Abstract][Full Text] [Related]
14. Leptin expression in breast nipple aspirate fluid (NAF) and serum is influenced by body mass index (BMI) but not by the presence of breast cancer.
Sauter ER; Garofalo C; Hewett J; Hewett JE; Morelli C; Surmacz E
Horm Metab Res; 2004 May; 36(5):336-40. PubMed ID: 15156414
[TBL] [Abstract][Full Text] [Related]
15. Influence of obesity and menopausal status on serum leptin, cholecystokinin, galanin and neuropeptide Y levels.
Milewicz A; Bidzińska B; Mikulski E; Demissie M; Tworowska U
Gynecol Endocrinol; 2000 Jun; 14(3):196-203. PubMed ID: 10923281
[TBL] [Abstract][Full Text] [Related]
16. Abdominal fat distribution in pre- and postmenopausal women: The impact of physical activity, age, and menopausal status.
Kanaley JA; Sames C; Swisher L; Swick AG; Ploutz-Snyder LL; Steppan CM; Sagendorf KS; Feiglin D; Jaynes EB; Meyer RA; Weinstock RS
Metabolism; 2001 Aug; 50(8):976-82. PubMed ID: 11474488
[TBL] [Abstract][Full Text] [Related]
17. Hormone and metabolic factors associated with leptin mRNA expression in pre- and postmenopausal women.
Fajardo ME; Malacara JM; Martínez-Rodríguez HG; Barrera-Saldaña HA
Steroids; 2004 Jun; 69(6):425-30. PubMed ID: 15219792
[TBL] [Abstract][Full Text] [Related]
18. Does tibolone affect serum leptin levels and body weight in postmenopausal women?
Gol M; Ozsener S; Sendag F; Uretmen S; Oztekin K; Tanyalcin T; Bilgin O
Arch Gynecol Obstet; 2005 Jul; 272(2):127-30. PubMed ID: 15517326
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers associated with breast cancer are associated with obesity.
Sauter ER; Scott S; Hewett J; Kliethermes B; Ruhlen RL; Basarakodu K; de la Torre R
Cancer Detect Prev; 2008; 32(2):149-55. PubMed ID: 18639389
[TBL] [Abstract][Full Text] [Related]
20. Serum leptin levels and body weight in postmenopausal women under transdermal hormone replacement therapy.
Salbach B; Nawroth PP; Kübler W; von Holst Th; Salbach PB
Eur J Med Res; 2000 Feb; 5(2):63-6. PubMed ID: 10720565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
